Position in PFE
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,171,178
-$193,650 QoQ
Shares Held
48,637
+0.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
#1,229
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Intellectus Partners, LLC holds $12,763,770 across 10 Drug Manufacturers - General names. PFE ranks #5 (9.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
11,595 | $2,917,765 | |
| 2 | LLY |
ELI LILLY & Co
|
1,918 | $2,300,506 | |
| 3 | NVO |
Novo Nordisk A S
|
33,631 | $1,612,270 | |
| 4 | MRK |
Merck & Co., Inc.
|
9,435 | $1,212,397 | |
| 5 | PFE |
Pfizer Inc
This page
|
48,637 | $1,171,178 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
8,947 | $1,130,363 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
17,002 | $979,655 | |
| 8 | JNJ |
Johnson & Johnson
|
2,801 | $711,369 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,171,178 | 48,637 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $1,364,828 | 48,605 | Shares | Sole | 2026-04-10 | |
| 2025-12-31 | $1,209,492 | 48,574 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $1,300,550 | 51,042 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,372,274 | 56,612 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $2,245,833 | 88,628 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $2,643,555 | 99,644 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $2,568,453 | 88,751 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $2,597,998 | 92,852 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $2,502,883 | 90,194 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $2,402,093 | 83,435 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $2,490,503 | 75,083 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $3,034,389 | 82,726 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $3,267,345 | 80,082 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $3,931,593 | 76,729 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $3,334,643 | 76,203 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,991,758 | 76,135 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $4,005,703 | 77,375 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $5,046,531 | 85,462 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,821,481 | 88,851 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $2,643,417 | 67,503 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $2,414,874 | 66,654 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $2,100,047 | 57,051 | Shares | Sole | 2021-02-18 | |
| 2020-09-30 | $1,679,647 | 45,767 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $875,412 | 26,771 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $881,311 | 27,001 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||